Sign In
Buy ELKEF
Elkem Asa Earnings Calls
| Release date | Jul 10, 2026 |
| EPS estimate | -$0.0833 |
| EPS actual | -$0.0151 |
| EPS Surprise | 81.94% |
| Revenue estimate | 378.321M |
| Revenue actual | 372.15M |
| Revenue Surprise | -1.63% |
| Release date | Apr 30, 2026 |
| EPS estimate | -$0.0257 |
| EPS actual | $0.0041 |
| EPS Surprise | 116.06% |
| Revenue estimate | 379.148M |
| Revenue actual | 418.185M |
| Revenue Surprise | 10.30% |
| Release date | Feb 13, 2026 |
| EPS estimate | -$0.0037 |
| EPS actual | -$0.0278 |
| EPS Surprise | -646.24% |
| Revenue estimate | 728.313M |
| Revenue actual | 722.063M |
| Revenue Surprise | -0.86% |
| Release date | Oct 31, 2025 |
| EPS estimate | $0.0006 |
| EPS actual | $0.0050 |
| EPS Surprise | 778.95% |
| Revenue estimate | 777.756M |
| Revenue actual | 753.278M |
| Revenue Surprise | -3.15% |
Last 4 Quarters for Elkem Asa
Below you can see how ELKEF performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Oct 31, 2025 |
| Price on release | $2.35 |
| EPS estimate | $0.0006 |
| EPS actual | $0.0050 |
| EPS surprise | 778.95% |
| Date | Price |
|---|---|
| Oct 27, 2025 | $2.60 |
| Oct 28, 2025 | $2.60 |
| Oct 29, 2025 | $2.60 |
| Oct 30, 2025 | $2.60 |
| Oct 31, 2025 | $2.35 |
| Nov 03, 2025 | $2.60 |
| Nov 04, 2025 | $2.60 |
| Nov 05, 2025 | $2.60 |
| Nov 06, 2025 | $2.60 |
| 4 days before | -9.62% |
| 4 days after | 10.64% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Feb 13, 2026 |
| Price on release | $3.10 |
| EPS estimate | -$0.0037 |
| EPS actual | -$0.0278 |
| EPS surprise | -646.24% |
| Date | Price |
|---|---|
| Feb 09, 2026 | $3.10 |
| Feb 10, 2026 | $3.10 |
| Feb 11, 2026 | $3.10 |
| Feb 12, 2026 | $3.10 |
| Feb 13, 2026 | $3.10 |
| Feb 17, 2026 | $3.10 |
| Feb 18, 2026 | $3.10 |
| Feb 19, 2026 | $3.10 |
| Feb 20, 2026 | $3.10 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Apr 30, 2026 |
| Price on release | $3.09 |
| EPS estimate | -$0.0257 |
| EPS actual | $0.0041 |
| EPS surprise | 116.06% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $3.09 |
| Apr 27, 2026 | $3.09 |
| Apr 28, 2026 | $3.09 |
| Apr 29, 2026 | $3.09 |
| Apr 30, 2026 | $3.09 |
| May 01, 2026 | $3.09 |
| May 04, 2026 | $3.09 |
| May 05, 2026 | $3.09 |
| May 06, 2026 | $3.09 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
| Release date | Jul 10, 2026 |
| Price on release | $3.40 |
| EPS estimate | -$0.0833 |
| EPS actual | -$0.0151 |
| EPS surprise | 81.94% |
| Date | Price |
|---|---|
| Jul 06, 2026 | $3.40 |
| Jul 07, 2026 | $3.40 |
| Jul 08, 2026 | $3.40 |
| Jul 09, 2026 | $3.40 |
| Jul 10, 2026 | $3.40 |
| Jul 13, 2026 | $3.40 |
| Jul 14, 2026 | $3.40 |
| Jul 15, 2026 | $3.40 |
| Jul 16, 2026 | $3.40 |
| 4 days before | 0% |
| 4 days after | 0% |
| On release day | 0% |
| Change in period | 0% |
Elkem Asa Earnings Call Transcript Summary of Q2 2026
Q2 highlights: Elkem continues its transformation with organizational streamlining complete after the Silicones sale, delivering cost reductions ahead of plan and accelerating deleveraging. The company raised NOK 1.8 billion equity, refinanced main bank facilities (new EUR 600m term loan + EUR 400m RCF) and secured a NOK 750m NIB loan, reducing net debt and improving leverage from ~5.0x to 3.2x (LTM EBITDA basis). Operationally, Silicon Products saw improved performance as Rana and Salten resumed production, while Carbon Solutions remained stable despite weak end markets. Market headwinds persist—weak China pricing, low global demand in key end markets (auto, construction, steel/aluminium)—but EU and US trade/regulatory measures could support a gradual price recovery. Elkem is pursuing strategic reviews across assets (Iceland has been reclassified as discontinued operations and is under strategic review), targeting NOK ~600m annual cost savings (now expected ~400 FTE reductions) and NOK 1bn working capital improvement this year. Investments are capped at NOK 1bn for 2026 to preserve cash. Management plans a Capital Markets Day likely in October to present further strategic details and targets.
